Annual Retained Earnings
-$337.58 M
-$48.82 M-16.91%
December 31, 2023
Summary
- As of February 8, 2025, ATNM annual retained earnings is -$337.58 million, with the most recent change of -$48.82 million (-16.91%) on December 31, 2023.
- During the last 3 years, ATNM annual retained earnings has fallen by -$106.61 million (-46.16%).
- ATNM annual retained earnings is now -174091.43% below its all-time high of -$193.80 thousand, reached on December 31, 2006.
Performance
ATNM Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$369.17 M
-$11.57 M-3.23%
September 30, 2024
Summary
- As of February 8, 2025, ATNM quarterly retained earnings is -$369.17 million, with the most recent change of -$11.57 million (-3.23%) on September 30, 2024.
- Over the past year, ATNM quarterly retained earnings has dropped by -$31.59 million (-9.36%).
- ATNM quarterly retained earnings is now -190392.26% below its all-time high of -$193.80 thousand, reached on December 31, 2006.
Performance
ATNM Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ATNM Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.9% | -9.4% |
| 3 y3 years | -46.2% | -49.0% |
| 5 y5 years | -80.7% | -80.8% |
ATNM Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.0% | at low | -44.4% | at low |
| 5 y | 5-year | -61.7% | at low | -76.8% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Actinium Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$369.17 M(+3.2%) |
| Jun 2024 | - | -$357.61 M(+3.3%) |
| Mar 2024 | - | -$346.25 M(+2.6%) |
| Dec 2023 | -$337.58 M(+16.9%) | -$337.58 M(+2.8%) |
| Sep 2023 | - | -$328.26 M(+4.2%) |
| Jun 2023 | - | -$314.98 M(+5.1%) |
| Mar 2023 | - | -$299.80 M(+3.8%) |
| Dec 2022 | -$288.76 M(+12.9%) | -$288.76 M(+3.8%) |
| Sep 2022 | - | -$278.12 M(+3.5%) |
| Jun 2022 | - | -$268.64 M(+3.0%) |
| Mar 2022 | - | -$260.88 M(+2.0%) |
| Dec 2021 | -$255.75 M(+10.7%) | -$255.75 M(+3.2%) |
| Sep 2021 | - | -$247.74 M(+2.7%) |
| Jun 2021 | - | -$241.31 M(+2.1%) |
| Mar 2021 | - | -$236.29 M(+2.3%) |
| Dec 2020 | -$230.97 M(+10.6%) | -$230.97 M(+2.8%) |
| Sep 2020 | - | -$224.59 M(+2.5%) |
| Jun 2020 | - | -$219.05 M(+2.2%) |
| Mar 2020 | - | -$214.43 M(+2.7%) |
| Dec 2019 | -$208.76 M(+11.7%) | -$208.76 M(+2.3%) |
| Sep 2019 | - | -$204.16 M(+3.3%) |
| Jun 2019 | - | -$197.56 M(+2.6%) |
| Mar 2019 | - | -$192.53 M(+3.0%) |
| Dec 2018 | -$186.86 M(+14.5%) | -$186.86 M(+3.5%) |
| Sep 2018 | - | -$180.54 M(+3.5%) |
| Jun 2018 | - | -$174.39 M(+2.9%) |
| Mar 2018 | - | -$169.47 M(+3.9%) |
| Dec 2017 | -$163.15 M(+19.5%) | -$163.15 M(+3.3%) |
| Sep 2017 | - | -$157.99 M(+4.2%) |
| Jun 2017 | - | -$151.67 M(+4.9%) |
| Mar 2017 | - | -$144.61 M(+5.9%) |
| Dec 2016 | -$136.55 M(+21.7%) | -$136.55 M(+5.2%) |
| Sep 2016 | - | -$129.86 M(+5.4%) |
| Jun 2016 | - | -$123.26 M(+5.7%) |
| Mar 2016 | - | -$116.63 M(+3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | -$112.23 M(+23.1%) | -$112.23 M(+6.2%) |
| Sep 2015 | - | -$105.69 M(+3.9%) |
| Jun 2015 | - | -$101.74 M(+7.9%) |
| Mar 2015 | - | -$94.28 M(+3.4%) |
| Dec 2014 | -$91.20 M(+37.1%) | -$91.20 M(+6.3%) |
| Sep 2014 | - | -$85.78 M(+7.6%) |
| Jun 2014 | - | -$79.70 M(-4.2%) |
| Mar 2014 | - | -$83.22 M(+25.1%) |
| Dec 2013 | -$66.52 M(+19.3%) | -$66.52 M(+9.7%) |
| Sep 2013 | - | -$60.64 M(+2.4%) |
| Jun 2013 | - | -$59.22 M(+4.9%) |
| Mar 2013 | - | -$56.43 M(+1.2%) |
| Dec 2012 | -$55.74 M(+17.6%) | -$55.74 M(>+9900.0%) |
| Sep 2012 | - | -$279.40 K(+1.3%) |
| Jun 2012 | - | -$275.70 K(+2.3%) |
| Mar 2012 | - | -$269.40 K(-99.4%) |
| Dec 2011 | -$47.38 M(>+9900.0%) | -$47.38 M(>+9900.0%) |
| Sep 2011 | - | -$257.10 K(+1.4%) |
| Jun 2011 | - | -$253.60 K(-7.5%) |
| Mar 2011 | - | -$274.10 K(+1.5%) |
| Dec 2010 | -$270.10 K(-0.6%) | -$270.10 K(+3.3%) |
| Sep 2010 | - | -$261.50 K(+3.8%) |
| Jun 2010 | - | -$251.90 K(-10.0%) |
| Mar 2010 | - | -$280.00 K(+3.1%) |
| Dec 2009 | -$271.70 K(+8.9%) | -$271.70 K(+3.6%) |
| Sep 2009 | - | -$262.20 K(+1.5%) |
| Jun 2009 | - | -$258.40 K(+1.5%) |
| Mar 2009 | - | -$254.70 K(+2.1%) |
| Dec 2008 | -$249.40 K(+14.3%) | -$249.40 K(+3.1%) |
| Sep 2008 | - | -$241.80 K(+1.4%) |
| Jun 2008 | - | -$238.50 K(+4.1%) |
| Mar 2008 | - | -$229.00 K(+4.9%) |
| Dec 2007 | -$218.20 K(+12.6%) | -$218.20 K(+7.0%) |
| Sep 2007 | - | -$204.00 K(+3.2%) |
| Jun 2007 | - | -$197.60 K(+2.0%) |
| Dec 2006 | -$193.80 K | -$193.80 K |
FAQ
- What is Actinium Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals annual retained earnings year-on-year change?
- What is Actinium Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals quarterly retained earnings year-on-year change?
What is Actinium Pharmaceuticals annual retained earnings?
The current annual retained earnings of ATNM is -$337.58 M
What is the all time high annual retained earnings for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high annual retained earnings is -$193.80 K
What is Actinium Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, ATNM annual retained earnings has changed by -$48.82 M (-16.91%)
What is Actinium Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of ATNM is -$369.17 M
What is the all time high quarterly retained earnings for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high quarterly retained earnings is -$193.80 K
What is Actinium Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, ATNM quarterly retained earnings has changed by -$31.59 M (-9.36%)